Targeted formulations of GLP -1 for Type 1 diabetes

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43DK069727-01
Agency Tracking Number: DK069727
Amount: $1,000,600.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
PHARMAIN, 650 BUCKTHORN TERR, BUFFALO GROVE, IL, 60089
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 ELIJAH Bolotin
 (847) 947-0900
 ebolotin@pharmain.com
Business Contact
Phone: (847) 947-0900
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): New therapies are desperately needed for patients with Type 1 diabetes. Recent reports that the insulin-stimulating hormone Glucagon-Like Peptide (GLP-1), can increase pancreatic beta cell mass, offers the exciting

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government